Skip to content

Protein Extrusion and Postprandial Amino Acid Handling

The Impact of the Extrusion Process During Dietary Protein Production on in Vivo Postprandial Amino Acid Availability

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05584358
Acronym
BABE
Enrollment
9
Registered
2022-10-18
Start date
2022-02-02
Completion date
2023-08-31
Last updated
2024-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postprandial Plasma Amino Acid Availability

Brief summary

The bulk of research that has investigated the effect of dietary protein on muscle tissue in humans has used isolated, minimally processed protein powders. However, the protein that we consume on a daily basis has typically undergone various processing methods, and evidence suggests these can change the way our bodies metabolise the protein. 'Extrusion' is a common processing method that uses high pressure to produce protein containing cereals and meat replacement foods. There is currently no research looking at how extrusion affects the way a protein source is digested and absorbed in humans. This study will compare the availability of ingested protein in the blood in the hours following consumption of an extruded versus a non-extruded source.

Interventions

DIETARY_SUPPLEMENTDry protein blend ingestion

Ingestion of protein blend powders mixed in water

DIETARY_SUPPLEMENTExtruded protein blend ingestion

Ingestion of protein blend powders mixed in water

Sponsors

Quorn
CollaboratorINDUSTRY
University of Exeter
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI between 18 and 30. * Metabolically healthy

Exclusion criteria

* Any metabolic impairments * cardio/pulmonary diseases. * Chronic use of the over the counter medicine * A personal or family history of epilepsy, seizures or schizophrenia. * Allergic to mycoprotein/Quorn/edible fungi/environmental mould products.

Design outcomes

Primary

MeasureTime frameDescription
Plasma amino acid concentrations5 hoursThe rate of appearance of amino acids ingested in the drink

Secondary

MeasureTime frameDescription
Blood glucose5 hoursThe concentrations of glucose in the blood
Serum insulin5 hoursThe concentration of insulin in the blood
Resting metabolic rate5 hoursThe amount of energy used to digest the protein

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026